BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis
USA - NASDAQ:BTSG - US10950A1060 - Common Stock
27.31 USD
+0.06 (+0.22%)
27.31 USD
0 (0%)
Taking everything into account, BTSG scores 4 out of 10 in our fundamental rating. BTSG was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSG get a neutral evaluation. Nothing too spectacular is happening here. BTSG is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year BTSG was profitable.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
1.2 Ratios
BTSG has a Return On Assets (1.10%) which is comparable to the rest of the industry.
BTSG has a Return On Equity (3.76%) which is in line with its industry peers.
With a Return On Invested Capital value of 4.19%, BTSG perfoms like the industry average, outperforming 51.49% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BTSG is significantly below the industry average of 9.19%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.1% | ||
| ROE | 3.76% | ||
| ROIC | 4.19% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
Looking at the Profit Margin, with a value of 0.55%, BTSG is in line with its industry, outperforming 50.49% of the companies in the same industry.
The Operating Margin of BTSG (1.96%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BTSG has grown nicely.
With a Gross Margin value of 12.88%, BTSG is not doing good in the industry: 67.33% of the companies in the same industry are doing better.
BTSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.55% | ||
| GM | 12.88% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
BTSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BTSG has been increased compared to 1 year ago.
Compared to 5 years ago, BTSG has more shares outstanding
BTSG has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.03 indicates that BTSG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.03, BTSG is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
The Debt to FCF ratio of BTSG is 13.29, which is on the high side as it means it would take BTSG, 13.29 years of fcf income to pay off all of its debts.
BTSG has a Debt to FCF ratio (13.29) which is in line with its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that BTSG has dependencies on debt financing.
BTSG has a worse Debt to Equity ratio (1.43) than 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 13.29 | ||
| Altman-Z | 3.03 |
ROIC/WACC0.47
WACC8.89%
2.3 Liquidity
A Current Ratio of 1.76 indicates that BTSG should not have too much problems paying its short term obligations.
The Current ratio of BTSG (1.76) is better than 63.37% of its industry peers.
A Quick Ratio of 1.34 indicates that BTSG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.34, BTSG perfoms like the industry average, outperforming 48.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 130.29% over the past year.
BTSG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.60%.
Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
3.2 Future
BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.52% yearly.
The Revenue is expected to grow by 12.46% on average over the next years. This is quite good.
EPS Next Y59.46%
EPS Next 2Y45.4%
EPS Next 3Y36.47%
EPS Next 5Y38.52%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 36.91, which means the current valuation is very expensive for BTSG.
Compared to the rest of the industry, the Price/Earnings ratio of BTSG is on the same level as its industry peers.
BTSG is valuated rather expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.49, BTSG is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSG is on the same level as its industry peers.
BTSG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.91 | ||
| Fwd PE | 23.49 |
4.2 Price Multiples
BTSG's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as BTSG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.31 | ||
| EV/EBITDA | 17.21 |
4.3 Compensation for Growth
BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 36.47% in the coming years.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y45.4%
EPS Next 3Y36.47%
5. Dividend
5.1 Amount
No dividends for BTSG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.31
+0.06 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners55.39%
Inst Owner Change2.79%
Ins Owners2.61%
Ins Owner Change19.83%
Market Cap4.84B
Analysts84.21
Price Target30.01 (9.89%)
Short Float %16.85%
Short Ratio6.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.63%
Min EPS beat(2)26.26%
Max EPS beat(2)97.01%
EPS beat(4)2
Avg EPS beat(4)20.64%
Min EPS beat(4)-38.02%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.05%
Min Revenue beat(2)2.86%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.58%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.62%
PT rev (3m)9.6%
EPS NQ rev (1m)10%
EPS NQ rev (3m)18.17%
EPS NY rev (1m)0%
EPS NY rev (3m)3.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.91 | ||
| Fwd PE | 23.49 | ||
| P/S | 0.4 | ||
| P/FCF | 25.31 | ||
| P/OCF | 18.02 | ||
| P/B | 2.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.21 |
EPS(TTM)0.74
EY2.71%
EPS(NY)1.16
Fwd EY4.26%
FCF(TTM)1.08
FCFY3.95%
OCF(TTM)1.52
OCFY5.55%
SpS67.66
BVpS9.84
TBVpS-6.61
PEG (NY)0.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.1% | ||
| ROE | 3.76% | ||
| ROCE | 5.3% | ||
| ROIC | 4.19% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 12.79% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.55% | ||
| GM | 12.88% | ||
| FCFM | 1.59% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 13.29 | ||
| Debt/EBITDA | 5.85 | ||
| Cap/Depr | 40.85% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 1.2 | ||
| Cash Conversion | 63.22% | ||
| Profit Quality | 291.7% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 3.03 |
F-Score7
WACC8.89%
ROIC/WACC0.47
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y59.46%
EPS Next 2Y45.4%
EPS Next 3Y36.47%
EPS Next 5Y38.52%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%
EBIT growth 1Y172.04%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year59.04%
EBIT Next 3Y24.94%
EBIT Next 5Y28%
FCF growth 1Y186.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y284.83%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%